In this Issue
More and More Treatments: Are We There Yet?
Tracy Ellyn uses fine art for healing purposes and epilepsy awareness.
GUEST MEDICAL EDITOR’S PAGE
New treatments—from cannabinoids to deep brain stimulation—may help meet the needs of still too many patients with uncontrolled seizures.
By Maromi Nei, MD
In this new column, we feature content from presenters at the 2018-2019 Philadelphia Neurological Society meetings.
By Stephen M. Gollomp, MD
What is the value of neuropsychologic testing for patients with MS when there are often no available treatments?
By Daniel Kantor, MD, FAAN, FANA
Neurologists need to understand the phenomenon of using psychedelic drugs for cluster-busting and advocate for appropriate research.
By Peter McAllister, MD
New formulations for rescue from the off period are coming.
By Jeffrey Lahrmann, MD; and Jill M. Giordano Farmer, DO
Mood disorders are significant comorbidities and frequently undertreated, despite growing evidence of benefits of treatment.
By Diana M. Rojas-Soto, MD
By Jason M. O’Dell, MS, CWM; and Michael Lewellen, CFP
COVER FOCUS: EPILEPSY
Neurosurgical techniques are effective and underutilized for patients with drug-resistant epilepsy.
By Joon Y. Kang, MD
From the vagal nerve to the deep brain, neuromodulation provides another treatment option for patients with epilepsy.
By Ahmad Soltani, MD; Isha Sharan; and Ashwini Sharan, MD
A new frontier brings new questions and old dilemmas.
By Adrian L. Turner, PharmD; and M. Scott Perry, MD
Ketogenic diets are an effective treatment when used properly with medical supervision and support.
By A. G. Christina Bergqvist, MD
As the number of available antiepileptic drugs increases, so does the challenge of choosing the most appropriate drug for a given patient.
By Alexander Doyle, MD; and Sasha Alick, MD
Guiding patients through contraceptive choices, prepregnancy planning, and pregnancy improves pregnancy outcomes.
By Frances Knapp; and Alison M. Pack, MD, MPH
Genetic testing is improving diagnostic accuracy and, sometimes, informing treatment decisions.
By Alica M. Goldman, MD, PhD, MS
A newly recognized category of epilepsy caused by or associated with antibodies.
By Lindsay M. Higdon, MD
Recent advances improve understanding of etiology, clinical and EEG findings, and clinical management for this category that comprises 20% of pediatric epilepsies.
By Delphi Barua, MD; and Arayamparambil C. Anilkumar, MD
SPOTLIGHT TOPIC: CONCUSSION
The settlement raises significant professional and ethical concerns for the field and practitioners of neurology.
By Francis X. Conidi, DO
Could this rare condition be related to vascular compression?